Business Oregon’s SBIR/STTR Matching Grant Program Provides Funds for Business Development Activities
Oregon City, Oregon, April 25, 2018 – NeuraMedica Inc. has been awarded a Business Oregon Small Business Innovation Research (SBIR) Phase I Matching Grant for $50,000. In December 2016, NeuraMedica received an SBIR Phase I grant through the National Science Foundation (NSF) for the development of a novel bioabsorbable clip and applier for durotomy repair in spinal surgery. The NSF SBIR grant provides funds for research and development work but does not cover additional commercialization activities, such as business plan development, marketing, or intellectual property protection. This Business Oregon Matching Grant will provide critical funds for intellectual property protection and corporate legal fees that are not covered by the NSF SBIR grant or other funding sources.
NeuraMedica Inc. is honored to receive this SBIR Phase I Matching Grant through the Oregon Innovation Fund. This Matching Grant is funded in part with Oregon State Lottery funds administered by the Oregon Business Development Department (OBDD). In addition to this Matching Grant, NeuraMedica Inc. has received Gap funding through the Oregon Nanoscience and Microtechnologies Institute (ONAMI) as well as a Biomedical Innovation Program award through the Oregon Clinical & Translational Research Institute (OCTRI) at Oregon Health & Science University (OHSU).
To learn more about the Business Oregon SBIR/STTR Matching Grant program, visit: https://www.oregon.gov/biz/programs/SBIR-STTR/Pages/default.aspx.
About the Business Oregon SBIR/STTR Matching Grant Program: As part of Oregon’s efforts to assist innovative companies and address gaps in federal SBIR/STTR programs, Business Oregon’s SBIR/STTR Matching Grant Program provides funding to help businesses build on projects and advance technologies developed using federal SBIR/STTR funds to help companies reach their next stage of growth. Business Oregon’s matching grants can be used on activities that cannot be covered by the federal SBIR/STTR grant funds and for things necessary for the company to move beyond the federally funded project and get closer to commercial production. The funds can be applied to expenses that help a company stay and grow in Oregon by furthering development of new technologies or products.
About NeuraMedica Inc.: NeuraMedica is a medical device company specializing in products for neurosurgery and other surgical specialties. NeuraMedica is located in Oregon City, Oregon and is a member of the growing medical device industry that now comprises over 700 Oregon-based, bioscience-related entities. NeuraMedica is both woman-owned and minority-owned (Native American) and is dedicated to contributing to the local economy by hiring the best candidates including those in underrepresented groups. The company was founded in 2014 by Biomedical Engineer Rachel Dreilinger (Co-founder and CEO) and Neurosurgeon Neil Roundy M.D. (Co-founder and Chief Medical Officer) to develop a straightforward solution to dural repair that benefits surgeons, hospitals, and patients. NeuraMedica aims to create a thriving company that is focused on commercializing devices for neurosurgery.NeuraMedica Inc. Contact Information:
Contact: Rachel Dreilinger [Co-Founder and CEO]